PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma

Completed · Phase 2

Conditions studied: Malignant Mesothelioma

In brief

RATIONALE: PTK787/ZK 222584 may stop the growth of tumor cells by blocking the enzymes necessary for tumor cell growth. PURPOSE: Phase II trial to study the effectiveness of PTK787/ZK 222584 in treating patients with unresectable malignant mesothelioma.

Key facts

Study ID
NCT00053885
Run by
Alliance for Clinical Trials in Oncology
People needed
47
Starts
2003-07-01
Expected to finish
2006-06-01
Last updated by the study team
2016-07-01

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.